Vertex Pharmaceuticals Corporation
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
Investors
%20.jpg)
Connections from
Last Funding Type:
Post-IPO Equity
Funding Status:
IPO
Headquarters:
Boston, Massachusetts, United States
Founded Date:
1989-01-01
Investor Type:
Company
Investment Stage:
N/A
Last Funding Date:
2022-05-17
Total Funding:
656200000.0
Technology:
Cancer
Employee Number:
1001-5000
Number Of Exists:
2
Acquisitions Number:
Made Acquisitions
Estimated Revenue:
$500M to $1B
Investors Number:
9.0
Industry:
Pharma